| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.04 |